Recall: D-297-2013

Class II - Potentially Harmful

Class IIClassification

2013-04-08Initiated

TerminatedStatus

Hospira Inc.Firm

Product

Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), 20 mL Single patient infusion vial, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4699-30.

Reason

Presence of Particulate Matter: A single visible particulate was identified during a retain sample inspection.

Distribution

Nationwide and Puerto Rico

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.